HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$2.61
Day range
$2.65 - $2.74
Year range
$2.10 - $14.22
Market cap
113.08M USD
Avg Volume
483.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 10.00M | — |
Operating expense | 28.28M | 39.35% |
Net income | -8.26M | 66.00% |
Net profit margin | -82.56 | — |
Earnings per share | -0.61 | 46.80% |
EBITDA | -18.27M | 9.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.37M | -54.46% |
Total assets | 105.75M | -44.85% |
Total liabilities | 65.74M | -4.74% |
Total equity | 40.01M | — |
Shares outstanding | 40.24M | — |
Price to book | 3.73 | — |
Return on assets | -39.86% | — |
Return on capital | -50.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -8.26M | 66.00% |
Cash from operations | -27.57M | -38.51% |
Cash from investing | 28.99M | 107.09% |
Cash from financing | -405.00K | -100.44% |
Net change in cash | 1.02M | -98.81% |
Free cash flow | -19.92M | -61.81% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Website
Employees
73
